Latest Medical cannabis Stories
The Canna Law Group, Seattle's leading medical cannabis business law firm, is expanding to the eastern side of the state. Seattle, Washington (PRWEB) May 02, 2013 The Canna Law Group is pleased to announce the opening of its second Washington office. The firm is expanding to Spokane to provide corporate transactional, licensing, and litigation services to the cannabis community on the eastern side of the state. Canna Law Group is the leading cannabis business law firm in Seattle....
A lightning-fast rejection by a key legislative committee in Connecticut put an effective end to a proposed regulation provision that was deemed "necessary" to jump-start Connecticut’s medical marijuana program. As a significant setback and a major loss for the patients who will be using medical marijuana as an alternative treatment option, MarijuanaDoctors is unraveling their new Titration Tracker program to track a marijuana patient's medicinal progress and prove that...
SAN GERONIMO, Calif., May 2, 2013 /PRNewswire/ -- Virogen Inc. (OTC:VRNI), a holding company with specialties in data security and encryption technology, today announced the launch of its newest business unit, "The Cannabis Connection", which is intended to operate medicinal marijuana dispensaries in states that have legalized such operations, including California. With an estimated current annual value of approximately $120 billion (legal and illegal) and expected continued easing...
DALLAS, May 2, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is cannabinoid extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, is proud to be part of the strategic team for 'American Drug War 2'. TheStockRadio.com interviewed Mr. Booth about the film and its National Release on June 6, 2013. The interview is available at...
Marijuana legalization movement receives over $100K for educational and political efforts SEATTLE, May 2, 2013 /PRNewswire/ -- At a news conference on the top floor of the tallest building in Seattle on Monday, the ArcView Investor Network announced some of the first outside angel investments in the new legal marijuana industry. More than 50 high net-worth private investors heard pitches from more than a dozen companies. By the end of the day, five companies received at least $1...
A dramatic genetic finding about autism and cannabinoids leads this month’s news, followed by spotlighting three cannabinoid activists for furthering science and a brief look at the US Supreme Court’s 1.3 grams of cannabis and deportation ruling. Chicago, IL (PRWEB) April 30, 2013 A dramatic genetic finding about autism and cannabinoids leads this month’s news from Publius, the pen name for the authors of The Cannabis Papers: A citizen’s guide to cannabinoids (2011). New research...
New research published in the Journal of Leukocyte Biology suggests compounds that stimulate the cannabinoid type 2 receptor in white blood cells, specifically macrophages, can weaken HIV-1 infection A new use for compounds related in composition to the active ingredient in marijuana may be on the horizon: a new research report published in the Journal of Leukocyte Biology shows that compounds that stimulate the cannabinoid type 2 (CB2) receptor in white blood cells, specifically...
SAN DIEGO, April 30, 2013 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA) To The Shareholders of Medical Marijuana Inc.: From: Michelle Sides, Chairman, Chief Operating Officer and Shareholder It has become apparent that the Company needs to pause momentarily and address the concerns of a number of our valued shareholders that have been posed to us from the numerous emails, postings, phone calls and the like as it pertains to the recent blog articles on MJNA. These attacks,...
Therapeutic Discovery Program initiated in the Netherlands, executed along U.S. guidelines for regulatory submission AMSTERDAM, April 26, 2013 /PRNewswire/ -- Cannabis Science, Inc. (OTC: CBIS) announced today the initiation of preclinical development characterization of CS-TATI-I following the execution of contractual retention of vendor labs located in the Amsterdam Life Science Cluster. Under the direction of Richard Ogden, PhD, Chief Scientific Officer, and Christopher...
The ArcView Group hosts news conference to announce angel investments in this promising sector. SEATTLE, April 24, 2013 /PRNewswire/ -- On Monday, April 29, 2013, more than 40 high-net-worth investors from around the world will gather in Seattle to hear pitches from the top entrepreneurs in the hot, new legal cannabis industry. The private event is hosted by The ArcView Investor Network. A news conference to announce some of the first funded deals will be held immediately...
